Introduction {#s1}
============

When acutely ill, animals engage in a behavioral sequence that includes cessation of feeding and body movements as well as reduced responsiveness to the environment. During acute infectious illness in mammals, electrophysiological correlates of sleep behavior are observed ([@bib43], [@bib44]), indicating that the behavioral sequence is sleep. In the arthropod *Drosophila melanogaster* ([@bib50]; [@bib22]) and the nematode *Caenorhabditis elegans* ([@bib11]), acute illness results in cellular stress, which then induces a sleep behavior: the animals stop moving and feeding, do not respond to weak stimuli but move normally in response to strong stimuli ([@bib11]). This stress-induced sleep (SIS, also known as sickness sleep) is beneficial to the animal and helps it recover from the acute injury ([@bib41]; [@bib11]; [@bib19]; [@bib8]). In fruit flies and round worms, environments that induce SIS include bacterial pathogens, bacterial toxins, heat shock, cold shock, osmotic shock, and ultraviolet light exposure ([@bib11]; [@bib22]). A comparison between mammalian sickness sleep and invertebrate SIS was recently reviewed ([@bib4]).

Nematode SIS is a distinct sleep state from a larval sleep state known as developmentally timed sleep (DTS) ([@bib45]), which is regulated by a homolog of the core circadian protein PERIOD ([@bib27]). In the absence of stress, nematodes experience sleep only when they transition between larval stages but do not sleep in the adult stage. Since *C. elegans* does not have an identifiable circadian rhythm of sleep, adult nematodes are an ideal system to study SIS in the absence of the circadian and homeostatic effects of animals that require daily sleep.

The mechanism of SIS is poorly-understood, yet a few common themes have emerged from studies across phylogeny. The acute illness can occur outside of the brain yet affect behavior, suggesting that communication occurs between non-neural and neural tissues. Cytokine signaling is involved. For example, in mammals, the cytokines interleukin-1 beta and tumor necrosis factor alpha, whose levels increase during an infectious challenge, are each sufficient to induce sleep when injected into the brain (reviewed in ([@bib17]). In nematodes ([@bib46]), arthropods ([@bib6]), and mammals ([@bib20]; [@bib16]), signaling by epidermal growth factor (EGF) is sufficient to induce sleep behavior and, at least in nematodes, EGF signaling is necessary for SIS ([@bib11]). These cytokines act on central nervous system (CNS) neurons, which then induce sleep.

In mammals, CNS neurons that regulate sleep reside in the hypothalamus ([@bib38]). In *C. elegans*, the target for EGF action is a single interneuron called ALA ([@bib46]), whose developmental program has similarities to the developmental program of mammalian neuroendocrine cells ([@bib47]). With EGF activation, ALA depolarizes to release neuropeptides encoded by the gene *flp-13* ([F]{.ul}MRFamide-[L]{.ul}ike [P]{.ul}eptide-13) to promote sleep ([@bib32]). FLP-13 peptides are characterized by an amidated Arginine-Phenylalanine (RFamide) motif at their C-termini. RFamide neuropeptides are involved in many physiological functions in both invertebrates ([@bib25]; [@bib33]), and vertebrates ([@bib36]; [@bib15]). In fruit flies, several RFamide neuropeptides regulate sleep ([@bib10]; [@bib39]), including the RFamide neuropeptide FMRFamide, which regulates SIS ([@bib22]).

In this study, we focused on understanding the downstream mechanism of the sleep-promoting activity of FLP-13 RFamide peptides. Both locomotion quiescence and feeding quiescence induced by *flp-13* can be reversed by activation of motor neurons ([@bib45]), suggesting that *flp-13* mediates quiescence at the level of the nervous system. Furthermore, quiescence induced by *flp-13* requires the G protein alpha subunit GOA-1 ([@bib45]), suggesting that these peptides signal through a G protein-coupled receptor (GPCR). There are more than 150 genes in the *C. elegans* genome predicted to encode neuropeptide receptor GPCRs ([@bib7]; [@bib13]). In prior detailed analysis of one of these GPCRs ([@bib31]), we showed that while FRPR-4 can be activated by FLP-13 peptides in cell-based assay, its genetic removal does not abrogate *flp-13* induced quiescence in vivo, suggesting that it is not the receptor mediating the quiescence-inducing effects of FLP-13 peptides in response to cellular stress. Since we had no strong *a priori* reason to implicate other specific GPCRs, we took a hypothesis-independent forward genetic screen approach to identify the FLP-13 receptor ([@bib51]). We here identify the GPCR DMSR-1 ([D]{.ul}ro[M]{.ul}yo[S]{.ul}uppressin [R]{.ul}eceptor related-1) as required for *flp-13* somnogenic effects. DMSR-1 is expressed in about one tenth of all *C. elegans* neurons and localizes diffusely to membranes. FLP-13 peptides can activate the receptor directly, indicating that DMSR-1 is likely an in vivo receptor for FLP-13 neuropeptides. Inhibition of neurons where *dmsr-1* is expressed enhances the effect of *flp-13*, suggesting that DMSR-1 transduces the FLP-13 signal by reducing activity of wake-promoting neurons.

Results {#s2}
=======

*dmsr-1* is required for *flp-13* induced sleep {#s2-1}
-----------------------------------------------

Our goal was to characterize the downstream mechanism for the sleep-inducing FLP-13 neuropeptides. We induced sleep by over expressing the *flp-13* gene in somatic cells under the control of the heat-inducible promoter *hsp-16.2* ([h]{.ul}eat-[s]{.ul}hock [p]{.ul}rotein-16.2). *Phsp-16.2:flp-13* transgenic animals are quiescent for body and pharyngeal movements two hours after exposure to a heat pulse to induce *flp-13* gene expression ([@bib32]). As previously described ([@bib51]) and illustrated in [Figure 1A](#fig1){ref-type="fig"}, we performed a forward mutagenesis screen to identify mutants with defective quiescence in response to *flp-13* overexpression. By performing genetic complementation tests, we determined that five of the identified mutants (*qn45*, *qn49*, *qn51*, *qn52* and *qn53*) were alleles of the same gene ([@bib51]). We found two additional alleles (*qn40* and *qn44*) in this gene by manually screening for mutants with defective feeding quiescence induced by overexpression of *flp-13*.10.7554/eLife.19837.003Figure 1.Mutations in the seven-transmembrane domain protein DMSR-1 suppress *flp-13* induced quiescence.(**A**) Mutagenesis approach to identify the downstream signaling mechanism for FLP-13 peptides. The grand-daughters of *Phsp-16.2:flp-13* worms that were mutagenized with the chemical ethyl methanesulfonate (EMS) were screened for rare animals that continued to feed and move after induction *flp-13* overexpression. Moving animals were selected using a microfluidics automated assay ([@bib51]) and feeding animals were identified by direct observation of pharyngeal pumping movements. (**B**) The DMSR-1 protein is predicted to have seven transmembrane domains with a C-terminus tail of either 145 amino acids (isoform A) or 87 amino acids (isoform B). Five mutations in DMSR-1 result in premature stop codons, one mutation results in an alanine to valine change in the second extracellular loop, and one mutation results in the removal of the C-terminal half of the protein. (**C**) Phylogenetic tree relationship between 30 *C. elegans* proteins previously demonstrated or predicted to be RFamide receptors, three *Drosophila melanogaster* RFamide receptors (NM_139501; NP_647713; NP_647711), and one receptor from each *Anopheles gambiae* (XP_314133) and *Rhodnius prolixus* ([@bib21]). Unless indicated otherwise, all proteins are from *Caenorhabditis elegans*. We drew a box to highlight DMSR-1 (isoform A). The evolutionary history was inferred by using the Maximum Likelihood method based on the JTT matrix-based model ([@bib14]). The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using a JTT model, and then selecting the topology with superior log likelihood value. The analysis involved 35 amino acid sequences. All positions containing gaps and missing data were eliminated. There were a total of 181 positions in the final dataset. Evolutionary analyses were conducted in MEGA7 ([@bib18]).**DOI:** [http://dx.doi.org/10.7554/eLife.19837.003](10.7554/eLife.19837.003)10.7554/eLife.19837.004Figure 1---figure supplement 1.DNA rearrangement of *dmsr-1* exon 4 in the *qn45* allele.(**A**) The *qn45* mutant allele involved a deletion of 332 nucleotides and a duplication of 54 nucleotides flanking the deletion, with a net loss of 278 nucleotides. This insertion/deletion (indel) is predicted to cause a frameshift resulting in an early stop codon. This indel was identified using Sanger sequencing. (**B**) Predicted amino acid sequence of wild type (N2) DMSR-1 and *qn45* DMSR-1 proteins. \* indicates STOP codon.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.004](10.7554/eLife.19837.004)

To identify the gene mutated to cause the defect in *flp-13* induced quiescence, we sequenced the genomes of six of the allelic mutants. Each of the six mutants had a mutation in *dmsr-1*, a gene predicted to encode a GPCR ([Figure 1B](#fig1){ref-type="fig"}). Four of the mutants (*qn44*, *qn49*, *qn51* and *qn53*) contained premature stop codons. One mutant (*qn45*) contained a complex rearrangement in exon 4 consisting of deletion of 332 nucleotides coupled with insertion of 54 nucleotides ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). This rearrangement results in a frame shift that eliminates the three transmembrane domains at the C-terminus of the protein. One mutant (*qn52*) contained an alanine to valine mutation in exon 3. We Sanger sequenced the *dmsr-1* gene in *qn40*, and found a premature stop mutation in exon 4 ([Figure 1B](#fig1){ref-type="fig"}). The six mutations which caused premature stops or a deletion are predicted to eliminate gene function. We do not know whether the missense mutation in *qn52* eliminates genes function; however, based on the phenotype and the relatively conservative alanine to valine mutation, the second extracellular loop where this mutation occurred likely plays an important role in the function of DMSR-1. We performed subsequent analyses using the *qn45* allele because it was a convincing null mutation and because the genotype could be easily determined using polymerase chain reaction (PCR).

DMSR-1 is one of 41 *C. elegans* proteins in the RFamide receptor family ([@bib7]) and is orthologous to *Drosophila* receptors for the neuropeptides dromyosuppressin and FMRFamide. Like FLP-13 peptides, Dromyosuppressin and FMRFamide are neuropeptides with an amidated Arginine-Phenylalanine (RFamide) motif at their C-terminus ([@bib28]). We grouped the *C. elegans* DMSR and other RFamide receptor proteins based on their sequence homology to the *Drosophila* myosuppressin receptors MsR1 and MsR2, which are known to respond to RFamide peptides ([Figure 1C](#fig1){ref-type="fig"}). Other RFamide receptors in *C. elegans* include FRPR ([F]{.ul}M[R]{.ul}Famide [P]{.ul}eptide [R]{.ul}eceptor family) proteins, and the neuropeptide receptor family (NPR), although these FRPR and NPR receptors are more closely related to the *Drosophila* FMRFaR than they are to the myosuppressin related receptors. We included in the phylogenetic tree other identified RFamide receptors from the arthropods *Anopheles gambiae* and *Rhodnius prolixus,* which also share homology to the Drosophila myosuppressin receptors. Based on its mutant phenotype and its homology to known RFamide receptors, we hypothesized that DMSR-1 is a receptor for FLP-13 neuropeptides.

To measure the degree to which these *dmsr-1* mutations suppressed the behavioral quiescence induced by *flp-13* overexpression, we subjected *Phsp-16.2:flp-13* transgenic animals to a heat pulse. We quantified feeding and locomotion quiescence two hours after induction of *flp-13* overexpression -- well after the acute effects of heat on quiescence have dissipated ([@bib32]). All wild-type animals pumped their pharynxes rapidly two hours after the heat pulse whereas the *Phsp-16.2:flp-13* transgenic animals showed little to no feeding movements ([Figure 2A--B](#fig2){ref-type="fig"}). By contrast, a significant fraction of each of the *dmsr-1* mutants had pharyngeal pumping movements despite overexpression of *flp-13* ([Figure 2A](#fig2){ref-type="fig"}). In the absence of a heat pulse, *dmsr-1(qn45)* mutants pumped rapidly at a rate no different from wild-type animals ([Figure 2B](#fig2){ref-type="fig"}). Following induction of *flp-13* overexpression, the rate of pumping in *dmsr-1(qn45)* mutants was not changed.10.7554/eLife.19837.005Figure 2.*dmsr-1* mutations suppress *flp-13* induced quiescence.(**A**) Fraction of animals quiescent for pharyngeal pumping two hours after induction of *flp-13* overexpression by exposure to a 30 min 33°C heat pulse. Statistical significance was assessed using a Fisher's exact test. N = 15--20 for each genotype. Asterisks indicate significant difference (p\<0.0001) compared to wild type animals two hours after heat pulse. (**B**) Rate of pharyngeal pumping in wild type or *dmsr-1(qn45)* mutants with or without the *Phsp16.2:flp-13* transgene comparing the behavior pre-heat pulse to two hours post-heat pulse. (**C**) Body movement quiescence in a two hour period starting two hours after induction of *flp-13* overexpression. (**D**) Total body movement activity in the same two-hour period as (**C**). Activity is the sum of pixels changed between sequential images. Statistical significance in panels B-D was assessed using a 2-Way ANOVA with post-hoc pairwise comparisons made using Bonferroni correction method. Error bars denote Mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.005](10.7554/eLife.19837.005)

To quantify body movements, we recorded worm activity and quiescence using the WorMotel ([@bib3]). The WorMotel is a polydimethylsulfoxane (PDMS) device consisting of 48 individual wells filled with agar nematode growth medium (NGM) and used to track individual worms over several hours. Two hours after induction of *flp-13* overexpression, we recorded body movement activity for two hours by taking images every 10 s. We used image subtraction analysis ([@bib35]) to determine both the total activity of the animals and the amount of time that each worm spent quiescent following induction of *flp-13* overexpression. Following induction of *flp-13* overexpression*, dmsr-1(qn45)* mutants had increased body movement activity and reduced body movement quiescence in comparison to animals that were wild type for *dmsr-1* ([Figure 2C--D](#fig2){ref-type="fig"}).

We can make a number of predictions based on the hypothesis that DMSR-1 is the receptor for FLP-13 neuropeptides. The first prediction is that, like *flp-13* ([@bib32]), *dmsr-1* should be required for quiescence during SIS. The second prediction is that FLP-13 neuropeptides will activate DMSR-1 in a cell-culture system. The third prediction is that *dmsr-1* should be expressed in the nervous system. Finally, DMSR-1 should be active in neurons that affect sleep/wake behavior.

DMSR-1 is required for stress induced sleep {#s2-2}
-------------------------------------------

In order to test whether *dmsr-1* is required for SIS, we first artificially activated the SIS pathway. In response to stress, the *C. elegans* EGF (called LIN-3) activates the EGF-receptor (called LET-23) on the ALA neuron ([@bib46]; [@bib11]). Overexpression of LIN-3/EGF produces a robust sleep state that mimics SIS ([@bib46]). While *dmsr-1* mutants showed wild-type levels of feeding quiescence in response to EGF overexpression ([Figure 3A](#fig3){ref-type="fig"}), they had a small but highly significant defect relative to wild-type worms in body movement quiescence ([Figure 3B](#fig3){ref-type="fig"}). This result provides evidence that *dmsr-1* is required downstream of or in parallel to EGF. The observation of only partial suppression of the EGF-induced quiescence suggests that there are other ALA-regulated signaling pathways working in parallel to *dmsr-1*.10.7554/eLife.19837.006Figure 3.*dmsr-1* mutants are defective in quiescence associated with stress-induced sleep.(**A**) Rate of pharyngeal pumping before and up to two hours following heat pulse induction of EGF/LIN-3C overexpression. *dmsr-1* does not suppress EGF induced feeding quiescence. (**B**) *dmsr-1(qn45)* partially suppresses body movement quiescence induced by EGF overexpression (*Phsp-16.2:lin-3*). Body movements were measured for two hours starting one hour after induction of EGF overexpression. (**C**) Rate of pharyngeal pumping in *dmsr-1(qn45)* mutants and *dmsr-1* genomic rescue during the first hour following 35°C heat shock to induce SIS. Rescue construct is the operon-based reporter shown in [Figure 5](#fig5){ref-type="fig"}. Asterisks denote significant difference compared to *dmsr-1(qn45)*. (**D**) Body movement quiescence during 90 min after a 35°C heat shock. The *dmsr-1(qn45)* mutation suppresses body movement quiescence in response to heat shock. This defect in quiescence is rescued by a genomic fragment containing *dmsr-1*. Statistical significance was assessed using a 2-Way ANOVA with post-hoc pairwise comparisons made using Bonferroni correction method. Error bars denote Mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.006](10.7554/eLife.19837.006)10.7554/eLife.19837.007Figure 3---figure supplement 1.*dmsr-1* mutants are defective in SIS triggered by different stressors but are not defective in developmentally timed sleep during lethargus.(**A**) Total body movement quiescence during the first hour after exposure to the indicated temperature for 30 min. Error bars denote SEM. \*\*\*p\<0.001. (**B**) Total body movement quiescence each hour after exposure to ultraviolet C (UVC) light. Error bars denote SEM. \*\*\*p\<0.001. (**C**) Total body movement quiescence in the three hours after the start of L4 lethargus. NS denotes p\>0.05.In panels A and B, statistical significance was assessed 2-Way ANOVA with post-hoc pairwise comparisons made using Bonferroni correction method, and in C with a two-tailed Student's t test.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.007](10.7554/eLife.19837.007)

To test the hypothesis that *dmsr-1* mediates SIS, we induced sleep by exposing the animals to a heat stress of 35°C for 30 min. *dmsr-1* mutations suppressed SIS with respect to both body movement quiescence and feeding quiescence ([Figure 3C--D](#fig3){ref-type="fig"}). To test whether *dmsr-1* was required for SIS after exposure to other temperatures, we exposed cohorts of animals to temperatures ranging from 29 to 37 degrees Celsius. The *dmsr-1(qn45)* mutation suppressed SIS at temperatures ranging from 34 to 37 degrees ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). To test whether *dmsr-1* was required for sleep in response to stressors other than heat, we exposed animals to ultraviolet C (UVC) radiation. UVC induced a strong body movement quiescent response, which was attenuated in the *dmsr-1(qn45)* mutant ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). We partially restored SIS in *dmsr-1* mutants by expressing a genomic fragment of *dmsr-1* including the coding region and 4 kb of upstream regulatory DNA ([Figure 3C,D](#fig3){ref-type="fig"}). It is possible that the incomplete rescue of SIS is due to an absence of *dmsr-1* in the full complement of cells where it acts. This incomplete expression may be due to the nature of our extrachromosomal DNA array, which is not inherited by every somatic cell. Alternatively, it is possible that the genomic DNA fragment does not contain all required *dmsr-1* regulatory elements. While *dmsr-1* mutants were defective in quiescence associated with SIS, they had normal quiescence associated with DTS ([Figure 3---figure supplement 1C--D](#fig3s1){ref-type="fig"}), as previously shown for *flp-13* mutants ([@bib32]), supporting the notion that the DTS and SIS are regulated at least partially differently ([@bib45]).

These experiments therefore demonstrate that, in response to cellular stress, *dmsr-1* is required for quiescence of feeding movements and body movements.

FLP-13 neuropeptides activate DMSR-1 in cell culture cells {#s2-3}
----------------------------------------------------------

To test the prediction that FLP-13 peptides activate DMSR-1 in cell culture, we cloned DMSR-1 isoform A into a mammalian expression vector and transiently expressed the protein in Chinese hamster ovarian (CHO) culture cells. These cells stably express a promiscuous Gα16 subunit as well as an aequorin reporter activated by intracellular calcium fluxes. Gα16 causes a Ca^2+^ flux in response to receptor activation regardless of the type of G-protein that couples to the receptor in vivo ([Figure 4A](#fig4){ref-type="fig"}) ([@bib1]).10.7554/eLife.19837.008Figure 4.FLP-13 peptides activate DMSR-1 in a cell-based system.(**A**) Signal transduction components in a cell system used to test for receptor activation by peptide ligands (L). DMSR-1A was expressed in CHO cells along with the calcium sensitive bioluminescent protein aequorin. The receptor was paired with the promiscuous human G~α16~ protein, which causes calcium release from intracellular storage sites upon receptor activation. The calcium response elicits a luminescent signal from aequorin, a calcium-activated protein. (**B**) FLP-13 peptide sequences. *flp-13* encodes seven distinct peptides (\* indicates that this peptide is encoded by the gene sequence twice). EC~50~ indicates the concentration of neuropeptide required to elicit 50% of the maximum luminescent response from the aequorin protein (as shown in **C**). (**C**) Dose response curves for the seven FLP-13 peptides. Error bars represent SEM from 8--12 trials of neuropeptide treatment. Line represents non-linear regression fit of a variable slope line using four parameters. The x-axis is shown on a logarithmic scale.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.008](10.7554/eLife.19837.008)

We measured the response of cells expressing DMSR-1 isoform A to a range of FLP-13 peptide concentrations. Since the FLP-13 protein is processed into seven distinct RFamide peptides ([Figure 4B](#fig4){ref-type="fig"}), we performed a dose-response study with each of these seven peptides. Each of these peptides was capable of activating DMSR-1. The most potent activator was FLP-13--5, which elicited a 50% maximal response (EC~50~) at a concentration of 2.3 nM ([Figure 4B--C](#fig4){ref-type="fig"}). The observed potent activation of DMSR-1 by FLP-13 peptides in this cell based assay supports the hypothesis that DMSR-1 is an *in vivo* receptor for FLP-13 peptides.

DMSR-1 is expressed in the nervous system {#s2-4}
-----------------------------------------

The third prediction made by our model is that *dmsr-1* is expressed in the nervous system. This prediction arises from prior studies indicating that the mechanism of feeding and movement quiescence observed with *flp-13* overexpression occurs through the inhibition of cholinergic motor neurons ([@bib45]). To test this prediction, we attached the rescuing genomic DNA of *dmsr-1* to a trans-splice acceptor site followed by the coding sequence of the red fluorescent protein dsRED ([Figure 5A](#fig5){ref-type="fig"}). This *Pdmsr-1:dmsr-1:SL2:dsRED* transgene rescued the *dmsr-1* mutant phenotype ([Figure 3C--D](#fig3){ref-type="fig"}), indicating that the construct contains regulatory elements required for appropriate *dmsr-1* expression. We observed red fluorescence in several neurons both in the head and tail of the animals ([Figure 5B](#fig5){ref-type="fig"}). Based on the location of the cell body, the neuronal process morphology, the co-expression of the transgene with other, well-characterized, green fluorescent protein (GFP) reporters, and the co-localization of the red fluorescence with green DiO fluorescence, we concluded that *dmsr-1* is expressed in the RID neuron ([Figure 5C](#fig5){ref-type="fig"}), the paired AIY neurons ([Figure 5D](#fig5){ref-type="fig"}), 12 other head neurons, the paired PHA and PHB neurons in the tail ([Figure 5E](#fig5){ref-type="fig"}), and in five other tail neurons.10.7554/eLife.19837.009Figure 5.DMSR-1 is expressed non-synaptically in the nervous system.(**A**) Schematic of operon (top) and promoter fusion (middle) transcriptional reporters used to determine expression pattern of *dmsr-1*. Schematic overview of *dmsr-1* expression pattern, with identified neurons labelled. (**B**) Example images of *dmsr-1* expression in head and tail. The images were processed by 3D deconvolution (Leica Application Suite X, Leica), and presented as a maximum projection of a Z-stack. In this and subsequent images, anterior is to the left. (**C**) Colocalization of *dmsr-1* promoter reporter with *kal-1* ([@bib48]) in the RID neuron. The *dmsr-1* promoter:mCherry reporter gave the same expression pattern as the operon-based transcriptional reporter shown in panel A. (**D**) Colocalization of *dmsr-1* mCherry reporter with *ttx-3* ([@bib12]) in an AIY neuron. Images were captured as a z-stack and processed by 3D deconvolution. One individual slice is shown. (**E**) DiO staining of tail phasmid neurons PHA and PHB, which colocalizes with the *dmsr-1* red reporter. (**F**) Lack of colocalization of *dmsr-1* promoter reporter with *nmr-1 ([@bib2])* in command interneurons. Images were captured as a z-stack and processed by 3D deconvolution. One deconvolved slice, which shows all three neuron types, is shown. There is a red neuron that partially overlaps the green AVE neuron but our close evaluation of multiple worms shows that these neurons are distinct. (**G**) Membrane localization of GFP attached to the C-terminus of DMSR-1 using a fosmid construct (TransgeneOme project).**DOI:** [http://dx.doi.org/10.7554/eLife.19837.009](10.7554/eLife.19837.009)10.7554/eLife.19837.010Figure 5---figure supplement 1.Rescue of the *dmsr-1* mutant quiescence-defective phenotype with a fosmid that encodes a GFP tag at the c-terminus of DMSR-1.(**A**) Body movement quiescence following UV exposure calculated in one hour intervals. Two-way repeated measures ANOVA with Bonferroni corrected comparisons for post-test. Comparisons are displayed as differences between the indicated line and *dmsr-1(qn45)* without the rescue construct. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001. (**B**) Body movement quiescence during the 8-hr period following UV exposure. One-way ANOVA with Tukey HSD post-test.\*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.010](10.7554/eLife.19837.010)10.7554/eLife.19837.011Figure 5---figure supplement 2.Effects of selective expression of *dmsr-1* in the paired AIY head neurons or in the paired PHA tail neurons.(**A**) Fraction of animals quiescent for pharyngeal pumping two hours after induction of *flp-13* overexpression using a 30 min 33°C heat pulse of *hsp16.2:flp-13* or control animals. Statistical significance was assessed using a Fisher's exact test. N = 15--20 for each genotype. (**B**) Pharyngeal pumping rates two hours after induction of *flp-13* overexpression using a 30 min 33°C heat pulse of *hsp16.2:flp-13* or control animals. Statistical significance was assessed using a 1-way ANOVA with Dunnett's post-hoc pairwise comparisons with *hsp16.2:flp-13; dmsr-1(qn45)* animals. (**C**) and (**D**) Body movement quiescence in a two-hour period starting at two hours after induction of *flp-13* overexpression. Statistical comparisons were made using 1-way ANOVA with Tukey HSD post-test. (**E**) Body movement quiescence for 60 min following a 30 min 35°C exposure to induce SIS. Statistical comparisons were made using 1-way ANOVA with Dunnett's post-hoc pairwise comparisons with *dmsr-1(qn45)* animals. (**F**) Pharyngeal pumping rate following a 30 min 35°C exposure to induce SIS. Two-way repeated measures ANOVA with Bonferroni corrected comparisons for post-test. Comparisons are displayed as differences between the indicated line and *dmsr-1(qn45)*.In all panels, bars denote the mean and SEM, ns denotes not significant, \* denotes p\<0.05, \*\*p\<0.01, and \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.011](10.7554/eLife.19837.011)

Based on additional analysis, we concluded that *dmsr-1* is not expressed in several other neurons, which are listed in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Importantly, we did not see expression of *dmsr-1* in AVE or AVA neurons ([Figure 5F](#fig5){ref-type="fig"}). These command interneurons are the only post-synaptic partners to the ALA neuron based on the presence of ultrastructurally-defined chemical synapses ([@bib49]). The expression in neurons that do not make direct synaptic connections with ALA suggested that ALA signals in a neuroendocrine fashion to promote SIS. In support of this suggestion, we found that a DMSR-1 protein with a GFP fluorescent tag at its C-terminus was localized diffusely to neuronal cell membranes and was not localized to synapses ([Figure 5G](#fig5){ref-type="fig"}). This GFP-tagged DMSR-1 protein rescued the mutant phenotype of *dmsr-1* ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), indicating that it was functional.

Taken together, these results support a model whereby ALA releases FLP-13 peptides in a neuroendocrine fashion to directly activate DMSR-1 expressed in neurons and thus promote sleep in response to cellular stress. The notion that ALA can signal via non-synaptic means was previously proposed based on the observation that a mutant with disrupted ALA axonal outgrowth retained normal ALA function ([@bib46]).

In an attempt to determine which of the neurons observed to express *dmsr-1* is sufficient to relay the sleep inducing effect of *flp-13* overexpression, we transgenically restored *dmsr-1* gene expression in specific neurons in animals otherwise lacking *dmsr-1* function. We tested two neuron types---AIY and PHA---where we had the tools to easily express DMSR-1 selectively in a single neuron type. Expression of *dmsr-1* in the paired PHA tail sensory neurons was not sufficient to restore feeding or body movement quiescence induced by *flp-13* overexpression ([Figure 5---figure supplement 2A--C](#fig5s2){ref-type="fig"}). Expression of *dmsr-1* in the paired head AIY interneurons conferred a small but statistically-significant (p\<0.01) rescue of the body movement quiescence defect ([Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}) but not the feeding quiescence defect observed in *dmsr-1* mutants during *flp-13* overexpression ([Figure 5---figure supplement 2A--B](#fig5s2){ref-type="fig"}). AIY specific *dmsr-1* expression did not however rescue the feeding or body movement quiescence defects observed in *dmsr-1* mutants during SIS ([Figure 5---figure supplement 2E--F](#fig5s2){ref-type="fig"}).

DMSR-1 acts to inhibit neuronal activity {#s2-5}
----------------------------------------

The fourth prediction from our model is that DMSR-1 signaling affects neurons that control sleep/wake behavior. DMSR-1 may regulate sleep either by activating sleep-promoting neurons or by inhibiting wake-promoting neurons. To distinguish between these possibilities, we inhibited the *dmsr-1*-expressing cells to test their effects on sleep. If DMSR-1 activation promotes sleep by activating sleep-promoting neurons, then inhibiting these neurons should impair sleep. Conversely, if DMSR-1 activation promotes sleep by inhibiting wake-promoting neurons, then inhibiting these cells would promote sleep.

We inhibited DMSR-1 expressing neurons by using histamine-gated chloride (HisCl) channels. We can use this approach because histamine does not appear to act as a neurotransmitter in *C. elegans* ([@bib13]). In the presence of histamine, HisCl channels allow chloride ions to pass into the neurons to render them less excitable ([@bib24]; [@bib32]; [@bib34]). By applying histamine to worms expressing HisCl channels under the control of the *dmsr-1* promoter (*Pdmsr-1:HisCl*), we inhibited *dmsr-1* expressing neurons in a spatially- and temporally- controlled fashion. Because non-transgenic animals lack endogenous receptors for histamine ([@bib34]), they behaved similarly in the presence and absence of histamine ([Figure 6](#fig6){ref-type="fig"}). When transgenic worms expressing *Pdmsr-1:HisCl* worms were placed on histamine, their movement quiescence and total activity were not affected ([Figure 6](#fig6){ref-type="fig"}), indicating that in the absence of cellular stress, silencing these neurons has minimal effect on behavior.10.7554/eLife.19837.012Figure 6.DMSR-1 has an inhibitory effect on neurons.(**A**) *Pdmsr-1:HisCl* worms were placed on histamine-containing agar, and sleep was induced by ultraviolet C (UVC) light irradiation. Worms were compared to the wild type strain (N2) on histamine, as well as to worms not exposed to histamine. Gray lines indicate control worms that were not exposed to UVC light, whose quiescence was not affected by activation of HisCl channels. Statistical comparisons were performed using a 2-way repeated measures ANOVA using time and experimental group as factors. Asterisks indicate lowest level of significance in comparisons between *Pdmsr-1:HisCl* on histamine with each of the other groups in pairwise comparison using Bonferroni correction. \*p\<0.05, \*\*p\<0.005, \*\*\*p\<0.0005. (**B**) Total amount of sleep over eight hours from [Figure 6A](#fig6){ref-type="fig"} for each individual worm. There was a significant interaction between histamine and HisCl channels such that HisCl channels only increased sleep in the presence of histamine. \*\*\*p\<0.0005. There were no significant effects found for worms that were not irradiated with UV. NS denotes not significant. (**C**) Total activity analysis across an eight-hour period. HisCl channels reduced activity only in animals exposed to histamine, and there were no significant effects for worms that were not irradiated with UV. \*\*\*p\<0.0005. NS denotes not significant. In all three panels, triangles represent animals that expressed Pdmsr-1:HisCl, circles represent animals that do not express Pdmsr-1:HisCl, filled symbols represent animals that have been exposed to histamine, empty symbols represent animals that have not been exposed to histamine, black symbols represent animals that have been exposed to UV irradiation, and gray symbols represent animals that were not exposed to UV irradiation. In panels B and C, statistical significance was assessed with a 2×2 Factorial ANOVA with Bonferroni post-hoc correction.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.012](10.7554/eLife.19837.012)

We then tested whether activating the HisCl channels affected activity and quiescence after triggering cellular stress. For these experiments, we triggered cellular stress by exposing the animals to ultraviolet (UV) light ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). UV light exposure triggers a robust sleep state that requires ALA and FLP-13 signaling (H. Debardeleben and D. Raizen, unpublished data). The long-lasting effects of UV induced sleep provide a sensitive tool for measuring the effects of neuronal silencing in this experiment. When HisCl worms were placed on histamine following exposure to UV stress, they had reduced total activity and enhanced body movement quiescence compared to control worms that lacked the HisCl channels ([Figure 6A--C](#fig6){ref-type="fig"}). Importantly, HisCl channels did not affect activity or quiescence in the absence of histamine.

These observations of elevated body movement quiescence with HisCl activation suggest that DMSR-1 promotes sleep by inhibiting wake-promoting cells.

*dmsr-1* and *flp-13* have parallel activity {#s2-6}
--------------------------------------------

One neuropeptide (or a group of neuropeptides encoded by the same gene) may activate multiple receptors. Similarly, a given receptor may be activated by multiple neuropeptides. Does the somnogenic effect of FLP-13 neuropeptides result exclusively from the activation of DMSR-1? Do other neuropeptides activate DMSR-1 to induce sleep? We used a double mutant analysis to answer these questions. We compared the SIS phenotypes of *flp-13; dmsr-1* double mutant animals to those of *dmsr-1* and *flp-13* single mutant animals. We reasoned that if *flp-13* and *dmsr-1* have sleep inducing effects that are independent of one another, then the double mutant will have a greater defect in SIS compared to either of the single mutants. The double mutant animals indeed showed a greater defect in quiescence than either the *dmsr-1* or the *flp-13* single mutant animals ([Figure 7](#fig7){ref-type="fig"}). This result suggests that (1) FLP-13 peptides activate receptors in addition to DMSR-1, and (2) DMSR-1 is either activated by ligands in addition to those encoded by *flp-13*, or DMSR-1 has ligand-independent activity.10.7554/eLife.19837.013Figure 7.DMSR-1 and FLP-13 neuropeptides have parallel activity.(**A**) Double mutant analysis between *flp-13* and *dmsr-1*. Total amount of body movement quiescence was measured following UV irradiation. Statistical comparisons were made using 2-way repeated measures ANOVA with post-hoc pairwise Bonferroni correction method and restricted to comparisons made with the double mutant. (**B**) Total quiescence during first four hour period following UV irradiation shown in [Figure 7A](#fig7){ref-type="fig"}. Statistical comparisons were made using 1-way ANOVA with Dunnett's post-hoc pairwise comparisons with the double mutant.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.013](10.7554/eLife.19837.013)

Discussion {#s3}
==========

Our findings expand our understanding of how stress induced sleep is regulated in *C. elegans* ([Figure 8](#fig8){ref-type="fig"}). Cellular stress leads to the release of the EGF/LIN-3 ([@bib11]) either from the stressed cells directly or from other cells. EGF activates the ALA neuron through the EGF-receptor LET-23 ([@bib46]). This activation requires depolarization of ALA ([@bib32]). ALA releases neuropeptides encoded by the *flp-13* gene ([@bib32]) as well as other neuropeptides ([@bib29]). FLP-13 neuropeptides then act in a neuroendocrine fashion to activate the G-protein coupled receptor DMSR-1 and thus to inhibit wake-promoting neurons, which include the AIY interneurons. The G-protein that is coupled to DMSR-1 may be the Gi/o alpha subunit GOA-1, since *goa-1* mutants are defective in SIS and in *flp-13* induced sleep ([@bib45]) and since *goa-1* is expressed widely in the nervous system ([@bib42]). GOA-1 signaling may ultimately down regulate the activity of the Gq (EGL-30) signaling pathway, since a gain of function mutation in EGL-30 suppresses *flp-13* induced sleep ([@bib45]).10.7554/eLife.19837.014Figure 8.Model for the regulation of stress-induced sleep.Cellular stress leads to the release of EGF (LIN-3) either directly from the stressed cells or indirectly via other cells receiving a signal from the stressed cells. EGF activates the ALA neuron by binding to the EGF receptor (LET-23). ALA depolarizes and releases FLP-13 neuropeptides, among other sleep inducing signals. FLP-13 peptides signal in a non-synaptic fashion via the seven-transmembrane domain receptor DMSR-1 and the G protein alpha subunit Gi/o to inhibit several wake-promoting neurons. These neurons include AIY, PHA, PHB, RID, and other neurons.**DOI:** [http://dx.doi.org/10.7554/eLife.19837.014](10.7554/eLife.19837.014)

The observation that the suppression of quiescence by most of our genetic manipulations is only partial suggests that there are additional complexities in the sleep promoting system downstream of ALA activation. Our double mutant analyses support the notion that FLP-13 peptides act on other receptors in addition to DMSR-1, and that DMSR-1 is activated by peptides other than FLP-13 peptides. The additional receptors responding to FLP-13 peptides may include one or more of the 15 other DMSR proteins encoded in the *C. elegans* genome ([Figure 1C](#fig1){ref-type="fig"}), and the additional peptides acting on DMSR-1 may include one or more of the other neuropeptides released from ALA ([@bib29]).

We showed that selective *dmsr-1* expression in the AIY neurons conferred a small but significant rescue of the *flp-13* overexpression-induced movement quiescence but did not confer a rescue of SIS. Three possibilities could reconcile these observations. (1) The endogenous FLP-13 peptides that act on the AIY neurons are released from a neuron other than ALA. (2) FLP-13 peptides act on AIY only when expressed at high levels and do not normally do so under physiological conditions. (3) Our SIS assay conditions were not sufficiently sensitive to identify a small rescue in SIS. Regardless of the explanation of these results, since the AIY interneurons are known to promote worm locomotion ([@bib9]; [@bib40]), our observations that *dsmr-1* is expressed in AIY and may function in AIY are consistent with the model that FLP-13/DMSR-1 signaling functions to inhibit wake-promoting neurons.

Although selective *dmsr-1* expression in neither AIY nor PHA neurons fully rescued the mutant quiescence phenotype, our findings do not exclude the possibility that *dmsr-1* functions selectively in a neuron type that we have not yet tested. Several of the other neurons expressing *dmsr-1* remain unidentified and may also promote waking activity. One possibility is the neuroendocrine RID neuron, which promotes forward locomotion ([@bib23]). The alternative to the model that *dmsr-1* functions in a small subset of the neurons where it is expressed is that *dmsr-1* is simultaneously required in several neurons to promote sleep in response to FLP-13 signaling. In this model, which we favor, restoring *dmsr-1* gene expression in only a subset of the neurons in which *dmsr-1* is required would not be sufficient to fully rescue the mutant phenotype.

In mammals, wake-promoting centers are distributed broadly across brainstem, basal forebrain, midbrain, and diencephalic structures, but sleep promoting neurons are anatomically restricted ([@bib38]). The ventrolateral preoptic area of the hypothalamus, which is proposed to be sleep-promoting, contains inhibitory projections to several wake-promoting neurons ([@bib37]). It is possible that *C. elegans* similarly has a diffuse wake-promoting circuit that can be inhibited by a central sleep-promoting system, the single ALA neuron. It remains to be seen whether sleep in response to acute illness in other animals functions in a similar fashion, but since RFamide and EGF signaling regulates sleep in arthropods too, it would not be unreasonable to propose that the molecular details and signaling concepts elucidated here are conserved across phylogeny.

Materials and methods {#s4}
=====================

Worm cultivation {#s4-1}
----------------

Worms were cultivated on the agar surface of NGM medium (1.7% agar), fed the OP50 derivative bacterial strain DA837 ([@bib5]), and maintained at 20 degrees Celsius unless noted otherwise. We found that the type of agar used affected the behavior of animals after heat shock. For experiments reported here we used only granulated agar (Apex, catalog number 20--275).

Strains used {#s4-2}
------------

N2

NQ570: *qnIs303\[Phsp-16.2:flp-13; Phsp-16.2:GFP; Prab-3:Cherry\]*

NQ793: *dmsr-1(qn40) V; qnIs303*

NQ810: *dmsr-1(qn44) V; qnIs303*

NQ792: *dmsr-1(qn45) V; qnIs303*

NQ814: *dmsr-1(qn49) V; qnIs303*

NQ51: *dmsr-1(qn51) V; qnIs303*

NQ52: *dmsr-1(qn52) V; qnIs303*

NQ53: *dmsr-1(qn53) V*; qnIs303

NQ915: *dmsr-1(qn45) V*

NQ602: *flp-13(tm2427)*

NQ943: *flp-13(tm2427) IV; dmsr-1(qn45) V*

PS5009: *pha-1(e2132ts) III* (?); *syEx723\[Phsp16.2:LIN-3C; Pmyo-2:GFP; pha-1(+)\]*

NQ978: *pha-1(e2132ts) III* (?); *dmsr-1(qn45)* V; *syEx723*

NQ990: *qnEx514\[Pdmsr-1:HisCl; Pttx-3:GFP*\]

NQ1006: *qnEx526\[Pdmsr-1:mCherry; Punc-122:GFP; pha-1(+); ladder\]*

NQ1083: *unc-119(ed3) III; qnEx585*\[*dmsr-1(fosmid)::GFP*; *pCFJ151\]*

NQ1055: *dmsr-1(qn45) V; qnEx569*\[*dmsr-1(fosmid)::GFP; Pttx-3:GFP*; 1 kb DNA ladder\]

NQ1111: *dmsr-1(qn45) V; qnEx602*\[*dmsr-1:SL2:dsRed; Pttx-3:GFP*; 1 kb DNA *ladder\]*

NQ1142: *dmsr-1(qn45); qnEx610\[Pttx-3:dmsr-1:SL2:dsRed; Pmyo-2:GFP; 1 kb DNA ladder\]*

NQ1145: *dmsr-1(qn45) V;qnIs303; qnEx610\[Pttx-3:dmsr-1:SL2:dsRed; Pmyo-2:GFP; 1 kb DNA ladder\];*

NQ1147: *dmsr-1(qn45) V; qnIs303; qnEx614\[Pgcy-17:dmsr-1:SL2:dsRed;Pmyo-2:GFP; 1 kb DNA ladder\]*

Molecular biology {#s4-3}
-----------------

We used the overlap extension PCR method to generate constructs for transgenic analysis ([@bib30]). Oligonucleotide sequences used for constructs and for sequencing are listed in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}.

Microinjection of extrachromosomal arrays was performed as described in [@bib26].

Whole genome sequencing was performed at the Wistar Institute Genomics Core Facility and bioinformatics analysis of the sequences was performed at the Wistar Institute Bioinformatics Core Facility.

Genetic crosses {#s4-4}
---------------

Crosses with *dmsr-1* were performed using either the balancer nT1, which expresses a dominant GFP, or by following the *qn45* deletion by PCR analysis using the primers oNQ1480 and oNQ1515.

Behavioral assays {#s4-5}
-----------------

Except for data shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, which was collected from fourth larval stage animals, all behavioral assays were performed in young adult worms. Worms were synchronized by picking larval stage four animals and performing the experiments the following day.

### SIS induction by heat {#s4-5-1}

Sleep was induced by exposing the worms to 35°C for 30 min by immersion of their housing Petri dish sealed with Parafilm strips in a circulating water bath and then recovered at room temperature. For experiments in which we assessed feeding behavior by direct observation, we immersed the worms housed on the agar surface of 5.5 cm diameter polystyrene Petri dishes (Azer, Catalog numbers ES3515 and ES3514) containing 10 mL of NGM agar and seeded with DA837 bacteria. For experiments in which we measured body movements using the WorMotel, worms were picked to the WorMotel chip and placed inside an empty plastic 10 cm diameter Petri dish, which was sealed with Parafilm and placed in the heat bath.

### Assessment of body movement activity and quiescence {#s4-5-2}

The set-up for imaging the WorMotel is described in [@bib3]. The WorMotel is a PDMS device that contains a series of wells filled with NGM agar so that individual worms can be housed separately for longitudinal tracking. The chip was imaged under dark field microscopy using red light to indirectly illuminate worms from below a glass stage as described. Images were taken every ten seconds at a spatial resolution of 16 microns per pixel. Images were analyzed using custom software that subtracts pairs of successive images as previously described ([@bib35]). Body movement activity was quantified as the total number of pixels changed in the subtracted images, and quiescent epochs were those in which no pixel movement was detected between a pair of frames. The software is available at <https://github.com/cfangyen/wormotel>.

### SIS induced by ultraviolet light exposure {#s4-5-3}

Sleep was induced by exposing worms to 1500 J/m^2^ of UVC light (XL-UV Crosslinker, Spectrolinker Incorporated). Worms were picked to the WorMotel chip with a thin coating of bacteria for food and placed in a 10 cm petri dish with the lid removed inside the crosslinker. Behavior was assessed by recording on the WorMotel.

### Heat-induced overexpression {#s4-5-4}

Overexpression of *flp-13* or of *lin-3* was induced in all somatic cells under the control of the heat shock inducible promoter *hsp-16.2*. Transcription was activated by immersing plates wrapped with Parafilm in a 33°C water bath for 30 min. To assess body movement quiescence, animals were exposed to heat while on NGM agar dishes, then transferred to the WorMotel chip and imaged. Feeding quiescence was measured two hours following induction of overexpression.

### Assessment of feeding behavior {#s4-5-5}

Feeding behavior was assessed by examining pharyngeal pumping under a stereomicroscope using 2-4x objective magnification. Behavior was measured in real time, and the experimenter was blinded to the condition of the worm. A pump was identified as a backwards movement of the grinder, a tooth-like structure in the posterior bulb of the pharynx.

### Histamine-gated chloride channels {#s4-5-6}

The coding region for the histamine-gated chloride channel was amplified using PCR from the pNP471 plasmid ([@bib34]), and combined with the *dmsr-1* promoter using overlap extension PCR. Worms were raised on NGM media and synchronized at the L4 stage. Young adults expressing *Pdmsr-1:HisCl* were placed in NGM agar medium with 15 mM histamine immediately prior to UV exposure and imaging on the WorMotel.

Statistics {#s4-6}
----------

Multi-factor analyses were performed using 2-way ANOVA with pairwise post-hoc comparisons using the Bonferroni correction. For post-hoc tests, all comparisons were made against one group. For time course analyses, we used a 2-way ANOVA with the time factor as a repeated measure. One factor analyses were performed using a 1-way ANOVA with pairwise comparisons made using Dunnett's test. All statistics were performed and graphs were generated using GraphPad Prism 5.0.3.477 and 6.0 (GraphPad Software, Inc., La Jolla California).

Receptor ligand interactions in cell culture {#s4-7}
--------------------------------------------

The assessment of FLP-13 peptide activation of DMSR-1 was done as described ([@bib31]). Briefly, DMSR-1A cDNA was cloned into the pcDNA3.1(+) TOPO expression vector (Thermo Fisher Scientific, Waltham Massachusetts). Receptor activation was studied in Chinese hamster ovary cells (CHO) stably expressing apo-aequorin (mtAEQ) targeted to the mitochondria as well as the human Galpha16 subunit. We used the CHO-K1 cell line (PerkinElmer, ES-000-A2) for receptor activation assays. Quality control and authentication was performed by determining the EC50 for reference agonists (e.g. ATP) in an AequoScreen calcium mobilization assay. A mycoplasma test was performed using the MycoAlert Mycoplasma (Lonza) detection kit. This cell line tested negative for mycoplasma.

The CHO/mtAEQ/Galpha16 cells were cultured in Ham's F12 medium (Sigma), containing 10% fetal bovine serum (FBS), 100 UI/ml of penicillin/streptomycin, 250 μg/ml Zeocin and 2.5 μg/ ml Fungizone (Amphoterin B). Cell lines were grown at 37°C in a humidified atmosphere of 5% CO2 and were diluted fifteen-fold every third day. CHO/mtAEQ/Galpha16 cells were transiently transfected with the DMSR-1 cDNA construct or the empty pcDNA3.1(+) vector using the Lipofectamine transfection reagent (Thermofisher Scientific), according to the manufacturer's instructions. Cells expressing the receptor were shifted to 28°C 1 day later, and collected 2 days post-transfection in BSA medium (DMEM/HAM's F12 with 15 mM HEPES, without phenol red, supplemented with 0.1% BSA) and loaded with 5 μM coelenterazine h (Thermo Fisher) for 4 hr to reconstitute the holo-enzyme aequorin. Cells (25,000 cells/well) were exposed to synthetic peptides in BSA medium, and aequorin bioluminescence was recorded for 30 s on a MicroBeta LumiJet luminometer (PerkinElmer, Waltham Massachusetts) in quadruplicate. For dose-response evaluations, after 30 s of ligand-stimulated calcium measurements, Triton X-100 (0.1%) was added to the well to obtain a measure of the maximum cell Ca^2+^ response. BSA medium without the peptides was used as a negative control and 1 μM ATP was used to check the functional response of the cells. Cells transfected with the pcDNA3.1 empty vector were used as a negative control for the effect of the receptor. EC50 values were calculated from dose-response curves, constructed using a computerized nonlinear regression analysis, with a sigmoidal dose-response equation (Prism 6.0).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"The RFamide receptor DMSR-1 regulates stress-induced sleep in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Eve Marder as the Senior Editor and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Patsy Dickinson (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Please note that both reviewers felt the paper would have substantial impact on the field, but also felt that editorial work would strengthen its impact. In this case, I believe it will be helpful for you to see the initial reviews because they are in essential agreement, and focus on queries that you should answer to make the manuscript more broadly accessible and useful.

*Reviewer \#1:*

This paper provides convincing evidence that the gene dmsr-1 encodes a receptor (DMSR-1) that is activated by FLP-13 peptides, and is important in controlling \'stress-induced sleep\', that is, quiescence induced by the effects heat stress or of EGF (presumably acting on the ALA neuron). Using a mutagenesis screen, the authors found that a number of mutants that failed to respond to overexpression of *flp-13*, and therefore presumably over-stimulation by the FLP-13 peptides had a variety of mutations in the *dmsr-1* gene, leading to a failed DMSR-1 receptor. They went on to show that the DMSR-1 receptor binds to the FLP-13 peptides, that it is required for stress-induced sleep, that the *dmsr-1* gene is expressed in the nervous system (in a number of specific neurons), and finally that the likely mechanism for the effects of DMSR-1 activation on stress-induced sleep are likely mediated by an inhibition of wake-promoting neurons rather than by an activation of sleep-inducing neurons.

The writing is clear, and it appears to me that the data are appropriately interpreted and make a strong case for their interpretation. Moreover, the manuscript should be of interest to a reasonably wide range of neuroscientists. The ability to manipulate the genetic makeup of *C. elegans*, together with the existing knowledge of the nervous system, make this a system that works very well for this study.

*Reviewer \#2:*

This manuscript identifies the GPCR DMSR-1 as a novel regulator of stress-induced sleep through an unbiased forward genetic screen for genes that suppress the effects of a sleep-promoting neuropeptide. Complex neural circuits regulate sleep, and investigating sleep regulation in the nematode\'s relatively simple nervous system has potential to identify defined circuits regulating this process, and how they are modulated by environmental change. These findings build upon previous work identifying the ALA neurons as mediating stress-induced changes in sleep by release of FLP-13 neuropeptide. The identification of DMSR-1 as a target of FLP-13 provides a system for examining neurohormonal modulation of sleep in response to environmental or physiological changes. The experiments are technically sound and will have broad impact on the sleep community. Below I list a number of comments, mostly minor, that I believe would increase the accessibility and impact of this manuscript.

1\) Because this journal is geared towards a generalist audience, greater description of the assays and interpretations of results would be helpful.

2\) It is not clear why heat was selected as a stressor to characterize SIS in DMSR mutants while UV was used in the HisCL experiments. Using 35 degrees? What about other stressors? It would be very interesting to know if the role of DMSR-1 is generalizable across difference stressors.

3\) The impacted would be aided by localizing DMSR-1 function. Speculate on what other. Is it at least possible to separate head and tail populations?

4\) In [Figure 7](#fig7){ref-type="fig"}, the double mutant effect almost looks additive, which is somewhat surprising. This experiment may benefit from a more detailed analysis e.g. a number of different UV intensities or heat gradients.

10.7554/eLife.19837.018

Author response

*Please note that both reviewers felt the paper would have substantial impact on the field, but also felt that editorial work would strengthen its impact. In this case, I believe it will be helpful for you to see the initial reviews because they are in essential agreement, and focus on queries that you should answer to make the manuscript more broadly accessible and useful.*

We thank the editor and the reviewers for spending the time to closely read the manuscript and for their constructive comments, which served to strengthen the manuscript. We performed additional experiments in an attempt to localize the function of *dmsr-1* within the nervous system. These new data are now shown in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}. We made editorial changes to the manuscript, as guided by the two reviewers' comments.

*Reviewer \#2:*

*\[...\] Below I list a number of comments, mostly minor, that I believe would increase the accessibility and impact of this manuscript.*

1\) Because this journal is geared towards a generalist audience, greater description of the assays and interpretations of results would be helpful.

We added greater details of the methods, the results, and our interpretation of the results.

*2) It is not clear why heat was selected as a stressor to characterize SIS in DMSR mutants while UV was used in the HisCl experiments.*

We currently have under review a manuscript showing that short wavelength ultraviolet light triggers sleep, and that this sleep is regulated by ALA and FLP-13, similar to the regulation of SIS by heat and other stressors described in Hill et al. and Nelson et al., 2014. Because UV induces quiescence over a longer time course, we have found that it is more sensitive for detecting the differences found in this figure. This rationale has been clarified in the text. In addition, we now introduce the use of UV at an earlier point in the paper, now in [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}.

*Using 35 degrees? What about other stressors? It would be very interesting to know if the role of DMSR-1 is generalizable across difference stressors.*

SIS can be triggered at other temperatures -- in general, the higher the temperature, the greater the subsequent behavioral response. Please see Figure 3 in Nelson et al., Current Biology 2014. To test whether *dmsr-1* is required for SIS after exposure to temperatures other than 35 degrees C, we performed an additional experiment in which we exposed cohorts of animals to 30 minutes of heat at temperatures ranging from 29 degrees Celsius to 37 degrees C. These new data are now shown in [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}.

To determine whether the role in *dmsr-1* can be generalized to other stressors, we performed an additional experiment in which we tested the effect of the mutant on sleep following exposure to ultraviolet C radiation. These new data are shown in [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}. Hence, indeed the role of *dmsr-1* in SIS appears to be generalizable to different degrees of stress and to different types of stress.

*3) The impacted would be aided by localizing DMSR-1 function. Speculate on what other. Is it at least possible to separate head and tail populations?*

We performed two cell-specific (AIY and PHA) rescue experiments but were unable to fully rescue the *dmsr-1* quiescence defect. With AIY-specific expression, we did find a small but statistically significant rescue of the *flp-13* overexpression-induced body movement quiescence, but no rescue of the *flp-13* overexpression-induced feeding quiescence and no rescue of the body movement or feeding movement quiescence during SIS. While it is certainly possible that *dmsr-1* function is required in a neuron type that we did not yet test, the explanation we favor is that *dmsr-1* function is simultaneously required in several neurons. We discuss these results in the context of our model of a distributed wake-promoting system.

*4) In [Figure 7](#fig7){ref-type="fig"}, the double mutant effect almost looks additive, which is somewhat surprising. This experiment may benefit from a more detailed analysis e.g. a number of different UV intensities or heat gradients.*

We agree that the double mutant has a stronger effect than either of the single mutants. We explain this finding by proposing that FLP-13 peptides are acting on other receptors and that the DMSR-1 receptor responds to other peptides. Performing a full dose response analysis of the stressors is unlikely to illuminate the interpretation of this double mutant phenotype.
